Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Comparison of Combined ACB and IPACK Versus ACB Alone for Postoperative Pain Management After ACL Reconstruction

18 november 2026 bijgewerkt door: Kazi Mahzabin Arin, Bangladesh Medical University

Evaluation of Combined Adductor Canal Block and Infiltration Between the Popliteal Artery and Capsule of the Knee (IPACK) Block Versus Adductor Canal Block (ACB) Alone on Postoperative Analgesia Following Anterior Cruciate Ligament (ACL) Reconstruction-A Randomized Controlled Trial

This randomized controlled trial aims to evaluate whether combining an adductor canal block (ACB) with an infiltration between the popliteal artery and the knee capsule (IPACK) provides better postoperative analgesia than ACB alone in patients undergoing anterior cruciate ligament reconstruction.

A total of 72 adult patients aged 18-50 years with American Society of Anesthesiologists (ASA) physical status I-II will be randomly allocated into two groups. The intervention group will receive ultrasound-guided combined ACB and IPACK blocks, while the comparator group will receive ultrasound-guided ACB alone. Both groups will receive spinal anesthesia and standardized postoperative analgesia.

Postoperative pain intensity will be assessed using the Numeric Rating Scale (NRS) at 2, 6, 12, and 24 hours after surgery. Other outcomes will include total opioid consumption during the first 24 hours, postoperative quality of recovery assessed by the QoR-15 questionnaire, time to first rescue analgesic request, maximum walking distance, and block-related complications.

The findings are expected to provide evidence on the effectiveness of adding an IPACK block to ACB to improve postoperative pain management following ACL reconstruction.

Studie Overzicht

Gedetailleerde beschrijving

Anterior cruciate ligament reconstruction (ACLR) is a commonly performed orthopedic procedure for patients with anterior cruciate ligament injuries. Despite its minimally invasive arthroscopic approach, the procedure is frequently associated with significant postoperative pain due to surgical tissue injury, graft harvesting, tourniquet application, and postoperative inflammatory responses. Inadequate pain management may interfere with early mobilization, delay rehabilitation, increase opioid consumption, and negatively affect postoperative recovery.

Effective postoperative analgesia is therefore an important component of perioperative care following anterior cruciate ligament (ACL) reconstruction. Multimodal analgesia, including regional anesthesia techniques, is increasingly used to improve pain control while minimizing opioid-related adverse effects.

The adductor canal block (ACB) is an ultrasound-guided regional anesthesia technique that primarily targets the saphenous nerve and provides analgesia to the anterior and medial aspects of the knee while generally preserving quadriceps muscle strength. However, adductor canal block (ACB) alone may provide inadequate analgesia for pain originating from the posterior aspect of the knee.

The infiltration between the popliteal artery and the knee capsule (IPACK) block is an ultrasound-guided regional anesthesia technique designed to provide analgesia to the posterior knee capsule while minimizing motor blockade. Combining infiltration between the popliteal artery and the knee capsule (IPACK) with adductor canal block (ACB) may provide more comprehensive postoperative analgesia by addressing both anterior-medial and posterior knee pain.

The present randomized controlled trial is designed to evaluate the effectiveness of combined ultrasound-guided adductor canal block (ACB) and infiltration between the popliteal artery and the knee capsule (IPACK) blocks compared with ultrasound-guided adductor canal block (ACB) alone in patients undergoing arthroscopic anterior cruciate ligament reconstruction.

The study will include 72 adult patients aged 18-50 years with American Society of Anesthesiologists (ASA) physical status I-II who are scheduled for anterior cruciate ligament (ACL) reconstruction. Participants will be recruited using consecutive sampling and randomly allocated 1:1 to two study groups using computer-generated block randomization. Allocation concealment will be maintained using sequentially numbered, opaque, sealed envelopes. The outcome assessor will remain blinded to the group allocation.

Participants allocated to this group will receive an ultrasound-guided adductor canal block with 20 mL of 0.25% bupivacaine, combined with an ultrasound-guided IPACK block with an additional 20 mL of 0.25% bupivacaine.

Participants allocated to this group will receive ultrasound-guided adductor canal block alone using 20 mL of 0.25% bupivacaine.

Both groups will undergo surgery under standard spinal anesthesia. Standardized postoperative analgesia will be provided using intravenous paracetamol (15 mg/kg) every 8 hours. Rescue analgesia with intravenous morphine (3 mg) will be administered when the postoperative Numeric Rating Scale (NRS) pain score exceeds 5, with repeat administration if required.

The study findings will help determine whether adding an IPACK block to an adductor canal block provides improved postoperative analgesia compared with ACB alone following ACL reconstruction.

Studietype

Ingrijpend

Inschrijving (Geschat)

72

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Contact Back-up

Studie Locaties

      • Dhaka, Bangladesh, 1000
        • Bangladesh Medical University
        • Contact:
        • Hoofdonderzoeker:
          • Mosharof Hossain, MD

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar tot 50 jaar (Volwassen)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Patient with anterior cruciate ligament injury requiring surgery.
  • Adult patients
  • Patients aged between 18 and 50 years
  • BMI
  • Patients of either sex.
  • American Society of Anesthesiologists (ASA) physical status I-II.

Exclusion Criteria:

  • Known allergy to local anesthetic drugs
  • Coagulopathy or patients receiving anticoagulant therapy
  • Infection at the site of injection
  • Chronic opioid use or opioid dependence
  • Pregnancy

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Group IPACK+ACB

Participants in this group will receive an ultrasound-guided adductor canal block (ACB) with 20 mL of 0.25% bupivacaine, combined with an ultrasound-guided infiltration between the popliteal artery and the knee capsule (IPACK) using an additional 20 mL of 0.25% bupivacaine. Both blocks will be administered before surgery. Standard spinal anesthesia and postoperative analgesia will be provided according to the study protocol.

Participants will receive an ultrasound-guided combined adductor canal block (ACB) and an infiltration between the popliteal artery and the knee capsule (IPACK) before surgery. The ACB will be performed using 20 mL of 0.25% bupivacaine administered around the saphenous nerve in the adductor canal. The IPACK block will be performed using an additional 20 mL of 0.25% bupivacaine injected into the interspace between the popliteal artery and the posterior capsule of the knee under ultrasound guidance. Both blocks will be administered as a combined regional anesthesia technique for postoperative pain management following anterior cruciate ligament reconstruction.

Actieve vergelijker: Group ACB

Participants in this group will receive an ultrasound-guided adductor canal block (ACB) alone using 20 mL of 0.25% bupivacaine before surgery. No IPACK block will be administered. Standard spinal anesthesia and postoperative analgesia will be provided according to the study protocol.

Ultrasound-guided adductor canal block will be performed with the participant in the supine position. A linear ultrasound transducer will be placed over the mid-thigh to identify the femoral artery and adjacent saphenous nerve beneath the sartorius muscle. After confirming needle placement and careful aspiration, 20 mL of 0.25% bupivacaine will be injected around the saphenous nerve in 5 mL increments.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Postoperative Pain Intensity Measured by Numeric Rating Scale (NRS)
Tijdsspanne: 2, 6, 12, and 24 hours after surgery

Postoperative pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain), both at rest and during movement (knee flexion greater than 45 degrees). Pain scores will be recorded and compared between the two study groups.

2, 6, 12, and 24 hours after surgery

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Time to First Analgesic Request
Tijdsspanne: First 24 hours after surgery

The time from the end of surgery to the first request for postoperative rescue analgesia will be recorded in hours and compared between the two study groups.

First 24 hours after surgery
Postoperative Quality of Recovery Measured by QoR-15 Score
Tijdsspanne: 24 hours after surgery

Postoperative quality of recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15). The total score ranges from 0 to 150, with higher scores indicating better recovery quality. Scores will be compared between the two study groups.

24 hours after surgery
Adverse Effects
Tijdsspanne: Up to 24 hours following surgery

Incidence of Block-Related Adverse Effects

Up to 24 hours following surgery
Total Opioid Consumption During the First 24 Hours After Surgery
Tijdsspanne: First 24 hours after surgery

Measure and compare the total opioid consumption between the two study groups during the first 24 hours after surgery. Opioid consumption will be recorded and expressed in morphine-equivalent doses (mg).

First 24 hours after surgery

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 december 2026

Primaire voltooiing (Geschat)

31 mei 2027

Studie voltooiing (Geschat)

31 mei 2027

Studieregistratiedata

Eerst ingediend

12 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

18 november 2026

Eerst geplaatst (Werkelijk)

20 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

20 november 2026

Laatste update ingediend die voldeed aan QC-criteria

18 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Bestudeer gegevens/documenten

  1. Leerprotocool
    Informatie-ID: pain.medicine@bmu.ac.bd

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren